Stacey R Dillon
5PUBLICATIONS
24CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Nov 04, 2024
A first-in-human, randomized study of the safety, pharmacokinetics and pharmacodynamics of povetacicept, an enhanced dual BAFF/APRIL antagonist, in healthy adults.Rupert Davies, Stanford L Peng, Jason Lickliter
|Mar 02, 2023
Non-Redundant Roles of T Cell Costimulation Pathways in Inflammatory Arthritis Revealed by Dual Blockade of ICOS and CD28 with Acazicolcept (ALPN-101).Stacey R Dillon, Lawrence S Evans, Katherine E Lewis
|Jan 27, 2023
Povetacicept, an Enhanced Dual APRIL/BAFF Antagonist That Modulates B Lymphocytes and Pathogenic Autoantibodies for the Treatment of Lupus and Other B Cell-Related Autoimmune Diseases.Lawrence S Evans, Katherine E Lewis, Daniel DeMonte
|Apr 05, 2022
The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity.Mark F Maurer, Katherine E Lewis, Joseph L Kuijper
|Oct 08, 2020
ICOSL+ plasmacytoid dendritic cells as inducer of graft-versus-host disease, responsive to a dual ICOS/CD28 antagonist.Djamilatou Adom, Stacey R Dillon, Jinfeng Yang
Pageof 1
Frequent Collaborators
3 joint publications
Stanford L Peng
1 joint publications
Djamilatou Adom
1 joint publications
Samantha Hund
1 joint publications
Katherine E Lewis
1 joint publications
Lawrence Evans
1 joint publications
Steven D Levin
1 joint publications
Sherri Mudri
1 joint publications
Jing Yang
1 joint publications
Erika Rickel
1 joint publications
Michelle Seaberg
